COVID-19

Cardiac Events in Adults Hospitalized for Respiratory Syncytial Virus vs COVID-19 or Influenza | Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants | Clinical Effectiveness of Oral Antiviral Treatment for Non-hospitalized High-risk Patients with COVID-19 During Omicron JN.1 Subvariant Wave: A U.S.-based Propensity-matched Cohort Study

Air and Surface Sampling for Clade Ib Monkeypox Virus in United Kingdom Hospitals, 2024 to 2025 | The Clinical Impact of Prolonged Steroid Therapy in Severe COVID-19 Patients: A Retrospective Cohort Study with Propensity Score Matching | Antibiotic Treatment in Patients Hospitalized for Nonsevere COVID-19 | Self-reported Health, Neuropsychological Tests and Biomarkers in Fully Recovered COVID-19 Patients vs Patients with Post-COVID Cognitive Symptoms: A Pilot Study

A Phase 3 Safety and Efficacy Study of Baloxavir Marboxil in Children Less Than 1 Year Old With Suspected or Confirmed Influenza | COVID-19 Infection History as a Risk Factor for Early Pregnancy Loss: Results from the Electronic Health Record-based Southeast Texas COVID and Pregnancy Cohort Study | Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical Trial

Live Zoster Vaccination and Cardiovascular Outcomes: A Nationwide, South Korean Study | Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants | Early Effectiveness of the BNT162b2 KP.2 Vaccine against COVID-19 in the U.S. Veterans Affairs Healthcare System

Tocilizumab and IVIG Experience During the Service Follow-up in Patients with Severe COVID-19 Pneumonia | Risk of New-Onset Type 2 Diabetes among Vaccinated Adults after Omicron or Delta Variant SARS-CoV-2 Infection

Efficacy, Safety, and Immunogenicity of the AS01E-adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over Three Respiratory Syncytial Virus Seasons (AReSVi-006): A Multicentre, Randomized, Observer-blinded, Placebo-Controlled, Phase 3 Trial | Long-Term Stroke and Mortality Risk Reduction Associated With Acute-Phase Paxlovid Use in Mild-to-Moderate COVID-19

Respiratory Syncytial Virus and Incidence of Cardiovascular Events: A Nationwide Self-Controlled Case Series Analysis | Comorbidities Associated with Different Degrees of Severity in Children and Young People Hospitalized with Acute COVID-19 | SHIELD-Utah Study Shows Novavax’s COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

Human Source SARS-CoV-2 Aerosol Transmission to Remote Sentinel Hamsters | Nirmatrelvir–ritonavir versus Placebo–ritonavir in Individuals with Long COVID in the USA (PAX LC): A Double-blind, Randomized, Placebo-controlled, Phase 2, Decentralized Trial | Quantitative Brain Volume Differences Between COVID-19 Patients and Non-COVID-19 Volunteers: A Systematic Review

Early Impact of RSV Vaccination in Older Adults in England | Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Associated Hospitalizations and Medically Attended COVID-19 among adults aged ≥18 years in the United States | Metformin Alleviates Inflammatory Response and Severity Rate of COVID-19 Infection in Elderly Individuals

Lower Levels of Household Transmission of SARS-CoV-2 Omicron Variant of Concern vs Wild Type: An Interplay Between Transmissibility and Immune Status | The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients with Kidney Disease: A Propensity Score–Matched Study | Effect of Pulmonary Rehabilitation for Patients with Long COVID-19: A Systematic Review and Meta-analysis of Randomized Controlled Trials